amantadine and zanamivir

amantadine has been researched along with zanamivir in 118 studies

Research

Studies (118)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (8.47)	18.2507
2000's	71 (60.17)	29.6817
2010's	35 (29.66)	24.3611
2020's	2 (1.69)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, G; Li, J; Ouyang, W; Pan, W; Tien, P; Wu, S; Yang, J; Yu, R; Zhang, F	1
Batta, G; Bereczki, I; Borbás, A; Fejes, Z; Herczegh, P; Kiss-Szikszai, A; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Török, Z	1
Cesur, N; Cesur, Z; Göktaş, F; Naesens, L; Vanderlinden, E	1
Batta, G; Bereczki, I; Borbás, A; Herczegh, P; Jóna, I; Kéki, S; Máté, G; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Vanderlinden, E	1
Chen, G; Pan, W; Tien, P; Wu, S; Yang, J; Yang, JX; Yu, R; Zhang, F	1
Fernández, R; Font-Bardia, M; Miquet, S; Naesens, L; Torres, E; Vanderlinden, E; Vázquez, S	1
Batta, G; Bereczki, I; Borbás, A; Dobray, L; Herczegh, P; Kéki, S; Kicsák, M; Naesens, L; Nikodém, ÉN; Ostorházi, E; Rozgonyi, F; Vanderlinden, E	1
Cichero, E; Costi, MP; Gazzarrini, S; Loddo, R; Moroni, A; Naesens, L; Santucci, M; Tasso, B; Tonelli, M	1
Barniol-Xicota, M; Caffrey, M; Codony, S; Ginex, T; Leiva, R; Luque, FJ; Montes, M; Naesens, L; Vanderlinden, E; Vázquez, S	1
Cichero, E; Costi, MP; Francesconi, V; Giordanetto, F; Giovannini, L; Naesens, L; Santucci, M; Tonelli, M	1
Batta, G; Borbás, A; Csávás, M; Herczegh, P; Kelemen, V; Le Thai, S; Naesens, L; Rőth, E; Stevaert, A; Szűcs, Z; Vanderlinden, E	1
Andrei, G; Cazin, I; Harej, A; Klobučar, M; Macan, AM; Pavelić, K; Pavelić, SK; Raić-Malić, S; Schols, D; Snoeck, R; Stepanić, V	1
Cui, M; Hu, A; Li, S; Lian, W; Lin, D; Liu, A; Xiao, M; Xu, L; Yan, X; Ye, J; Zhang, M; Zhao, J	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Dempsey, MH; Penn, CR; Ryan, DM; Ticehurst, J	1
Couch, RB	2
Mossad, SB	2
Barnett, JM; Hiscox, SA; Morris, SJ; Price, GE; Smith, H; Sweet, C	1
Fleming, DM	3
Silagy, CA	1
Deeks, J; Demicheli, V; Jefferson, T; Rivetti, D	2
Keating, MR	1
Goldman, MP; Long, JK; Mossad, SB	1
Fearon, M; Lee, C; Li, Y; Loeb, M; Mazzulli, T; McArthur, MA; McGeer, A; Nesbitt, J; Phillips, A; Smith, K	1
Caserta, MT; Hall, CB	1
Ashley, JV; Gum, KD; Montalto, NJ	1
Rosen, DS	1
Briganti, E; Calza, L; Chiodo, F; Manfredi, R	1
Matsumoto, K	1
Tooley, P	1
Preboth, M	1
Holdiness, MR	1
Gross, PA	1
Hayden, FG	1
Sugaya, N	3
Farr, BM; Hall, KK; Hayden, FG; Salgado, CD	1
Bridges, CB; Cox, NJ; Fukuda, K; Singleton, JA; Uyeki, TM	1
Prober, CG	1
Englund, JA	1
Uyeki, T; Winquist, A	1
Roberts, MS; Smith, KJ	1
Dumyati, G; Falsey, AR	1
Uyeki, TM	1
Bazin, H; Cavallo, JD; Hernandez, E; Lhonneux, A; Noury, J; Ramisse, F	1
Balasingam, S; Bossuyt, S; Lambkin, R; Mann, A; Novelli, P; Oxford, JS	1
Mitamura, K	2
Kirkbride, HA; Watson, J	1
Bellantonio, S; Rose, DN; Rothberg, MB	1
Myers, JW	1
Elias, S; Fenton, R; Herlocher, ML; Klimov, A; Monto, AS; Ohmit, SE; Truscon, R	1
Ikematsu, H	1
Kashiwagi, S	1
Pegram, PS; Williamson, JC	1
Lu, Q	1
Härtl, A; Sauerbrei, A; Stelzner, A; Wutzler, P	1
Di Natale, R; Guy, RJ; Hampson, AW; Kelly, HA; Lambert, SB; Robinson, PM; Tallis, G; Tobin, S	1
Kossow, KD; Lode, H; Ruf, BR; Scholz, H; Vogel, GE; Wutzler, P	1
Fagan, HB; Moeller, AH	1
Hansen, L	2
Suzuki, H	1
Brandstaedt, A; Haertl, A; Sauerbrei, A; Schmidtke, M; Wutzler, P	1
Barr, IG; Brown, L; Hurt, AC; Komadina, N; Selleck, P; Shaw, R	1
Dwyer, DE; Emery, S; Harrod, ME	1
Hayden, FG; Pavia, AT	1
Brydak, LB; Gawryluk, D; Machała, M; Wiatr, E	1
Bauer, K; Schmidtke, M; Schrader, C; Suess, J; Wutzler, P	1
Lynch, JP; Walsh, EE	1
Wesseling, G	1
Worrall, G	1
Chidiac, C	1
Nüesch, R	1
Monto, AS	1
Balish, A; Bright, RA; Deyde, VM; Gubareva, LV; Klimov, AI; Lindstrom, S; Nguyen, T; Shu, B	1
Cooper, K; Jackson, R; Nicholson, K; Read, R; Rees, A; Simpson, E; Tappenden, P	1
Oxford, JS	1
Nayak, JL; Treanor, JJ	1
Baranovich, T; Dapat, C; Dapat, IC; Hasegawa, G; Kyaw, Y; Lin, N; Myint, YY; Naito, M; Nishikawa, M; Oo, HN; Oo, KY; Saito, R; Saito, T; Suzuki, H; Suzuki, Y; Win, N; Zaraket, H	1
Fujita, N; Horikawa, H; Kageyama, T; Kato, Y; Kishida, N; Mochizuki, K; Obuchi, M; Odagiri, T; Shimabukuro, K; Shirakura, M; Tashiro, M; Ujike, M; Yamashita, K	1
Baranovich, T; Caperig-Dapat, I; Dapat, C; Dbaibo, GS; Medlej, F; Reda, M; Saito, R; Suzuki, H; Suzuki, Y; Tabet, C; Wakim, R; Zaraket, H	1
Lundgren, J; Madsen, L; Nielsen, A	1
Ishii, H; Kadota, J; Tokimatsu, I; Yoshioka, D	1
Watanabe, A	1
Cooper, KL; Jackson, RJ; Nicholson, KG; Read, RC; Rees, A; Simpson, EL; Tappenden, P	1
Li, JF; Shen, JS; Xiong, RS; Zhang, Q; Zhao, QJ	1
Hankins, RW; Hattori, H; Iida, H; Miyachi, K; Takano, T; Ukai, H; Watanabe, A	1
Razonable, RR	1
Arnold, K; Baumbach, J; Bennett, NM; Doshi, S; Finelli, L; Fry, AM; Gershman, K; Hancock, EB; Kamimoto, L; Lynfield, R; Morin, C; Perez, A; Reingold, A; Ryan, P; Schaffner, W; Thomas, A; Yousey-Hindes, K; Zansky, S	1
Baumeister, E; Campos, AM; Pontoriero, A; Savy, VL	1
Akl, EA; Alonso-Coello, P; Brozek, J; Chen, YL; Cheung, A; Flottorp, SA; Hopkins, JP; Hovhannisyan, G; Hsu, J; Ivanova, L; Mustafa, R; Saeterdal, I; Santesso, N; Schünemann, HJ; Smaill, F; Tian, J; Uyeki, TM; Wong, AD	1
Azuma, T; Nakada, N; Tanaka, H; Yamashita, N	1
Sato, R	1
Cen, S; He, Z; Li, XY; Liu, ZL; Wang, X; Wang, Z; Wei, XL; Yin, X; Zhang, ZZ; Zhou, JM	1
Król, E; Rychłowska, M; Szewczyk, B	1
Ali, Z; Dapat, C; Dapat, IC; Dbaibo, G; Ghanem, S; Kayali, G; Kondo, H; Lteif, M; Saito, K; Saito, R; Suzuki, H; Zaraket, H	1
Li, F; Ma, C; Wang, J	1
Ariza-Heredia, EJ; Chemaly, RF; Shahani, L	1
Behzadian, F; Kananizadeh, P; Moeini, S; Mozhgani, SH; Pakzad, R; Zarei Ghobadi, M	1

Reviews

56 review(s) available for amantadine and zanamivir

Article	Year
Underused options for preventing and treating influenza. Cleveland Clinic journal of medicine, 1999, Volume: 66, Issue:1 Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Drug Administration Routes; Female; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Orthomyxoviridae; Pyrans; Ribavirin; Rimantadine; Sialic Acids; Zanamivir	1999
Prevention and early treatment of influenza in healthy adults. Vaccine, 2000, Jan-06, Volume: 18, Issue:11-12 Topics: Adolescent; Adult; Amantadine; Antiviral Agents; Cost-Benefit Analysis; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Middle Aged; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2000
Antiviral agents for non-human immunodeficiency virus infections. Mayo Clinic proceedings, 1999, Volume: 74, Issue:12 Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir	1999
Measures for control of influenza. PharmacoEconomics, 1999, Volume: 16 Suppl 1 Topics: Amantadine; Amines; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	1999
Antiviral agents for treating influenza. Cleveland Clinic journal of medicine, 2000, Volume: 67, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2000
Neuraminidase inhibitors for preventing and treating influenza in healthy adults. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Adult; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Pyrans; Sialic Acids; Zanamivir	2000
Updated treatment for influenza A and B. American family physician, 2000, Dec-01, Volume: 62, Issue:11 Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir	2000
[Influenza]. Recenti progressi in medicina, 2000, Volume: 91, Issue:12 Topics: Acetamides; Amantadine; Antiviral Agents; Disease Outbreaks; Guanidines; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Influenza, Human; Italy; Orthomyxoviridae; Oseltamivir; Pyrans; Sialic Acids; United States; Zanamivir	2000
[Antiinfluenza-drugs and the standard of the use]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:11 Topics: Acetamides; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Zanamivir	2000
Managing influenza: amantadine, rimantadine and beyond. International journal of clinical practice, 2001, Volume: 55, Issue:3 Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Neuraminidase; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2001
Adverse cutaneous reactions to influenza vaccinations and chemotherapy. International journal of dermatology, 2001, Volume: 40, Issue:7 Topics: Acetamides; Amantadine; Antiviral Agents; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Skin; Zanamivir	2001
Vaccines for pneumonia and new antiviral therapies. The Medical clinics of North America, 2001, Volume: 85, Issue:6 Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Centers for Medicare and Medicaid Services, U.S.; Child; Global Health; Guanidines; Health Priorities; Humans; Incidence; Influenza Vaccines; Joint Commission on Accreditation of Healthcare Organizations; Morbidity; Neuraminidase; Oseltamivir; Patient Selection; Pneumococcal Vaccines; Pneumonia; Primary Prevention; Pyrans; Rimantadine; Safety; Sialic Acids; United States; Vaccination; Zanamivir	2001
Perspectives on antiviral use during pandemic influenza. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2001, Dec-29, Volume: 356, Issue:1416 Topics: Acetamides; Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Multiple, Viral; Drug Tolerance; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2001
Influenza in the acute hospital setting. The Lancet. Infectious diseases, 2002, Volume: 2, Issue:3 Topics: Acetamides; Amantadine; Antiviral Agents; Cross Infection; Disease Outbreaks; Guanidines; Hospitals; Humans; Influenza Vaccines; Influenza, Human; Nursing Staff, Hospital; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Vaccination; Virginia; Zanamivir	2002
Antiviral therapy for influenza virus infections. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:1 Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Child; Clinical Trials as Topic; Global Health; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2002
Antiviral therapy of influenza. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:2 Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Drug Resistance, Viral; Guanidines; Humans; Infant; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2002
The management of influenza in people of working age. Occupational medicine (Oxford, England), 2002, Volume: 52, Issue:5 Topics: Acetamides; Adolescent; Adult; Amantadine; Antiviral Agents; Cost-Benefit Analysis; Guanidines; Humans; Influenza, Human; Middle Aged; Occupational Health; Oseltamivir; Pyrans; Sialic Acids; United Kingdom; Workplace; Zanamivir	2002
Influenza. Clinical evidence, 2002, Issue:7 Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Randomized Controlled Trials as Topic; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir	2002
Antivirals for influenza: what is their role in the older patient? Drugs & aging, 2002, Volume: 19, Issue:10 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2002
Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. The Pediatric infectious disease journal, 2003, Volume: 22, Issue:2 Topics: Acetamides; Adolescent; Age Distribution; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; DNA, Viral; Female; Fluorescent Antibody Technique, Direct; Follow-Up Studies; Guanidines; Humans; Incidence; Infant; Influenza, Human; Male; Orthomyxoviridae; Oseltamivir; Pyrans; Risk Assessment; Severity of Illness Index; Sex Distribution; Sialic Acids; Treatment Outcome; United States; Zanamivir	2003
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:1 Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Endemic Diseases; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir	2003
[Influenza]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Acetamides; Amantadine; Antiviral Agents; Diagnosis, Differential; Enzyme Inhibitors; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Reagent Kits, Diagnostic; Sialic Acids; Vaccines, Attenuated; Zanamivir	2003
[Antiviral agents for influenza]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir	2003
Review of the use of neuraminidase inhibitors for prophylaxis of influenza. Communicable disease and public health, 2003, Volume: 6, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Health Planning; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2003
Influenza therapy. Southern medical journal, 2003, Volume: 96, Issue:8 Topics: Acetamides; Adult; Age Factors; Amantadine; Antiviral Agents; Child; Cost-Benefit Analysis; Creatine; Disease Outbreaks; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Influenza, Human; Kidney Failure, Chronic; Metabolic Clearance Rate; Oseltamivir; Patient Selection; Primary Prevention; Pyrans; Sialic Acids; Treatment Outcome; Zanamivir	2003
[Clinical characteristic of the elderly in influenza infection]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:11 Topics: Age Factors; Aged; Amantadine; Antiviral Agents; Chromatography; Enzyme Inhibitors; Guanidines; Humans; Immunoenzyme Techniques; Influenza Vaccines; Influenza, Human; Neuraminidase; Pneumonia, Viral; Prognosis; Pyrans; Reagent Kits, Diagnostic; Risk; Sialic Acids; Zanamivir	2003
[Criteria for the use of anti-influenza agents]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:11 Topics: Acetamides; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Practice Guidelines as Topic; Prodrugs; Pyrans; Sialic Acids; Time Factors; Virus Latency; Zanamivir	2003
Neuraminidase inhibitors in patients with underlying airways disease. American journal of respiratory medicine : drugs, devices, and other interventions, 2002, Volume: 1, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Asthma; Bronchial Spasm; Comorbidity; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive; Pyrans; Rimantadine; Risk Factors; Sialic Acids; Zanamivir	2002
What is the best antiviral agent for influenza infection? American family physician, 2004, Oct-01, Volume: 70, Issue:7 Topics: Acetamides; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Contraindications; Evidence-Based Medicine; Family Practice; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2004
Influenza. Clinical evidence, 2003, Issue:10 Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2003
[Super pathogenic avian influenza]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Nov-10, Volume: 93, Issue:11 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Chickens; Disease Outbreaks; Guanidines; Humans; Influenza A virus; Influenza in Birds; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Poultry Diseases; Pyrans; Sialic Acids; Zanamivir; Zoonoses	2004
Influenza. Clinical evidence, 2004, Issue:12 Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2004
[Anti-virals for influenza virus infection]. Uirusu, 2005, Volume: 55, Issue:1 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Drug Utilization; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Japan; National Health Programs; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Zanamivir	2005
Antivirals in the management of an influenza pandemic. The Medical journal of Australia, 2006, 11-20, Volume: 185, Issue:S10 Topics: Amantadine; Antiviral Agents; Australia; Community-Acquired Infections; Disease Outbreaks; Drug Resistance, Viral; Government Programs; Humans; Infection Control; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; World Health Organization; Zanamivir	2006
Which agents should we use to treat and prevent influenza in 2006-2007? Cleveland Clinic journal of medicine, 2006, Volume: 73, Issue:11 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir	2006
Antiviral therapy and prophylaxis for influenza in children. Pediatrics, 2007, Volume: 119, Issue:4 Topics: Adamantane; Amantadine; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Influenza, Human; Male; Oseltamivir; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Rimantadine; Risk Assessment; Severity of Illness Index; Treatment Outcome; Zanamivir	2007
[Antiviral agents for influenza]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Viral Matrix Proteins; Zanamivir	2007
Influenza: evolving strategies in treatment and prevention. Seminars in respiratory and critical care medicine, 2007, Volume: 28, Issue:2 Topics: Aged; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Child, Preschool; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Ribavirin; Rimantadine; United States; Zanamivir	2007
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment. International journal of chronic obstructive pulmonary disease, 2007, Volume: 2, Issue:1 Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Rimantadine; Zanamivir	2007
[Influenza]. La Revue du praticien, 2008, Feb-29, Volume: 58, Issue:4 Topics: Adolescent; Adult; Age Factors; Aged; Amantadine; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Diagnosis, Differential; Female; Follow-Up Studies; France; Humans; Infant; Influenza Vaccines; Influenza, Human; Male; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Seasons; Time Factors; Treatment Outcome; Zanamivir	2008
[Antiviral treatment of influenza in humans]. Therapeutische Umschau. Revue therapeutique, 2007, Volume: 64, Issue:11 Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Virus Replication; Virus Shedding; Zanamivir	2007
Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. Health technology assessment (Winchester, England), 2009, Volume: 13, Issue:11 Topics: Amantadine; Antiviral Agents; Cost-Benefit Analysis; Humans; Influenza, Human; Models, Economic; Oseltamivir; Practice Guidelines as Topic; Premedication; Randomized Controlled Trials as Topic; Seasons; Treatment Outcome; Zanamivir	2009
Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza and other respiratory viruses, 2007, Volume: 1, Issue:1 Topics: Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza, Human; Oseltamivir; Rimantadine; Zanamivir	2007
Antiviral treatment and prophylaxis of influenza virus in children. Pediatric annals, 2009, Volume: 38, Issue:12 Topics: Amantadine; Antiviral Agents; Chemoprevention; Child; Child, Preschool; Enzyme Inhibitors; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Post-Exposure Prophylaxis; Zanamivir	2009
[Current anti-influenza virus chemotherapy]. Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:9 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Drug Utilization; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Infusions, Intravenous; Japan; Oseltamivir; Pandemics; Zanamivir	2010
[Present and future in development of new anti-influenza drugs]. Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:9 Topics: Amantadine; Antiviral Agents; DNA-Directed RNA Polymerases; Drug Design; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir	2010
Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review. The Journal of infection, 2011, Volume: 62, Issue:1 Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Post-Exposure Prophylaxis; Treatment Outcome; Viral Matrix Proteins; Zanamivir	2011
[Research progress of anti-influenza virus agents]. Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:3 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Guanidines; Humans; Indoles; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrrolidines; Rimantadine; Structure-Activity Relationship; Viral Matrix Proteins; Zanamivir	2010
Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clinic proceedings, 2011, Volume: 86, Issue:10 Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir	2011
Antiviral drugs for influenza. The Medical letter on drugs and therapeutics, 2012, Jan-09, Volume: 54, Issue:1381 Topics: Adult; Amantadine; Antiviral Agents; Child; Female; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Pregnancy; Rimantadine; Zanamivir	2012
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Annals of internal medicine, 2012, Apr-03, Volume: 156, Issue:7 Topics: Administration, Inhalation; Administration, Oral; Amantadine; Antiviral Agents; Confounding Factors, Epidemiologic; Hospitalization; Humans; Influenza, Human; Oseltamivir; Rimantadine; Treatment Outcome; Zanamivir	2012
[Drug resistance of influenza viruses]. Nihon Jibiinkoka Gakkai kaiho, 2012, Volume: 115, Issue:7 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Viral Matrix Proteins; Zanamivir	2012
Antivirals--current trends in fighting influenza. Acta biochimica Polonica, 2014, Volume: 61, Issue:3 Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Viral Matrix Proteins; Zanamivir	2014
Inhibitors targeting the influenza virus hemagglutinin. Current medicinal chemistry, 2015, Volume: 22, Issue:11 Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Hemagglutinin Glycoproteins, Influenza Virus; Neuraminidase; Orthomyxoviridae; Oseltamivir; Rimantadine; Zanamivir	2015
Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:4 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir	2017
Prevalence of human influenza virus in Iran: Evidence from a systematic review and meta-analysis. Microbial pathogenesis, 2018, Volume: 115 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Female; Humans; Incidence; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Iran; Male; Oseltamivir; Prevalence; Zanamivir	2018

Other Studies

62 other study(ies) available for amantadine and zanamivir

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2 Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Synthesis and antiviral activities of novel gossypol derivatives. Bioorganic & medicinal chemistry letters, 2012, Feb-01, Volume: 22, Issue:3 Topics: Anti-HIV Agents; Antiviral Agents; Gossypol; HIV-1; Humans; Influenza A Virus, H5N1 Subtype; Inhibitory Concentration 50; Models, Molecular; Molecular Structure	2012
Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities. Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23 Topics: Anti-Bacterial Agents; Antiviral Agents; Cell Line; Cell Survival; Drug Resistance, Viral; Gram-Positive Bacteria; Herpesvirus 1, Human; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Isoindoles; Microbial Sensitivity Tests; o-Phthalaldehyde; Teicoplanin	2012
Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives. Bioorganic & medicinal chemistry, 2012, Dec-15, Volume: 20, Issue:24 Topics: Adamantane; Amides; Animals; Antiviral Agents; Aza Compounds; Chickens; Dogs; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Madin Darby Canine Kidney Cells; Microwaves; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Virus Replication	2012
Synthesis of fluorescent ristocetin aglycon derivatives with remarkable antibacterial and antiviral activities. European journal of medicinal chemistry, 2012, Volume: 58 Topics: Anti-Bacterial Agents; Antiviral Agents; Dose-Response Relationship, Drug; Doxorubicin; Fluorescence; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Orthomyxoviridae; Structure-Activity Relationship	2012
Design, synthesis and biological evaluation of small molecular polyphenols as entry inhibitors against H(5)N(1). Bioorganic & medicinal chemistry letters, 2014, Jun-15, Volume: 24, Issue:12 Topics: Antiviral Agents; Drug Design; Influenza A Virus, H5N1 Subtype; Inhibitory Concentration 50; Models, Molecular; Polyphenols; Small Molecule Libraries; Structure-Activity Relationship; Virus Internalization	2014
Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds. ACS medicinal chemistry letters, 2012, Dec-13, Volume: 3, Issue:12 Topics:	2012
Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies. Bioorganic & medicinal chemistry letters, 2014, Aug-01, Volume: 24, Issue:15 Topics: Animals; Antiviral Agents; Binding Sites; Dogs; Dose-Response Relationship, Drug; Lipid Bilayers; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Molecular Structure; Orthomyxoviridae; Structure-Activity Relationship; Teicoplanin	2014
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus. European journal of medicinal chemistry, 2017, Jul-28, Volume: 135 Topics: Antiviral Agents; Crystallography, X-Ray; Dose-Response Relationship, Drug; Folic Acid Antagonists; Humans; Influenza A Virus, H1N1 Subtype; Influenza B virus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Proguanil; Respiratory Syncytial Viruses; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines	2017
Aniline-Based Inhibitors of Influenza H1N1 Virus Acting on Hemagglutinin-Mediated Fusion. Journal of medicinal chemistry, 2018, 01-11, Volume: 61, Issue:1 Topics: Aniline Compounds; Binding Sites; HeLa Cells; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Protein Conformation; Virus Internalization	2018
Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR). European journal of medicinal chemistry, 2018, Jul-15, Volume: 155 Topics: Antiviral Agents; Aza Compounds; Dose-Response Relationship, Drug; Folic Acid Antagonists; Models, Molecular; Molecular Structure; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines	2018
Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents. European journal of medicinal chemistry, 2018, Sep-05, Volume: 157 Topics: Antiviral Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Influenza A virus; Influenza B virus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Teicoplanin	2018
Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives. European journal of medicinal chemistry, 2019, Dec-15, Volume: 184 Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Ascorbic Acid; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles; Viruses	2019
Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors. European journal of medicinal chemistry, 2021, Mar-05, Volume: 213 Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Influenza A Virus, H3N2 Subtype; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Neuraminidase; Structure-Activity Relationship; Thiazoles	2021
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:10 Topics: Amantadine; Animals; Antiviral Agents; Guanidines; Influenza A virus; Influenza B virus; Mice; Neuraminidase; Orthomyxoviridae Infections; Pyrans; Ribavirin; Sialic Acids; Virus Replication; Zanamivir	1994
A new antiviral agent for influenza--is there a clinical niche? The New England journal of medicine, 1997, Sep-25, Volume: 337, Issue:13 Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Neuraminidase; Pyrans; Rimantadine; Sialic Acids; Zanamivir	1997
Role of neuraminidase in influenza virus-induced apoptosis. The Journal of general virology, 1999, Volume: 80 ( Pt 1) Topics: alpha-Fetoproteins; Amantadine; Amino Acid Sequence; Ammonium Chloride; Animals; Antiviral Agents; Apoptosis; Base Sequence; Cell Line; DNA, Viral; Dogs; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Molecular Sequence Data; N-Acetylneuraminic Acid; Neuraminidase; Pyrans; Sialic Acids; Substrate Specificity; Time Factors; Ultraviolet Rays; Zanamivir	1999
Treating influenza with zanamivir. Lancet (London, England), 1999, Feb-20, Volume: 353, Issue:9153 Topics: Administration, Inhalation; Amantadine; Antiviral Agents; Biological Availability; Drug Resistance, Microbial; Guanidines; Humans; Influenza, Human; Orthomyxoviridae; Pyrans; Sialic Acids; Time Factors; Zanamivir	1999
Treating influenza with zanamivir. Management of Influenza in the Southern Hemisphere Trialists. Lancet (London, England), 1999, Feb-20, Volume: 353, Issue:9153 Topics: Administration, Inhalation; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Guanidines; Humans; Influenza, Human; Orthomyxoviridae; Pyrans; Rimantadine; Sialic Acids; Time Factors; Zanamivir	1999
Two neuraminidase inhibitors for treatment of influenza. The Medical letter on drugs and therapeutics, 1999, Oct-08, Volume: 41, Issue:1063 Topics: Acetamides; Administration, Inhalation; Administration, Oral; Amantadine; Amines; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Prodrugs; Pyrans; Sialic Acids; Zanamivir	1999
Drugs for non-HIV viral infections. The Medical letter on drugs and therapeutics, 1999, Dec-03, Volume: 41, Issue:1067 Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Amantadine; Animals; Anti-HIV Agents; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enzyme Inhibitors; Famciclovir; Ganciclovir; Guanidines; Guanine; Herpes Simplex; Herpes Zoster; History, 18th Century; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Lamivudine; Neuraminidase; Oseltamivir; Pyrans; Rats; Ribavirin; Sialic Acids; Teratogens; Valacyclovir; Valine; Zanamivir	1999
Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home. Infection control and hospital epidemiology, 2000, Volume: 21, Issue:11 Topics: Activities of Daily Living; Administration, Inhalation; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Microbial; Guanidines; Homes for the Aged; Humans; Influenza A virus; Influenza, Human; Middle Aged; Nursing Homes; Ontario; Patient Compliance; Pyrans; Sialic Acids; Zanamivir	2000
Antiviral agents for influenza. Pediatric annals, 2000, Volume: 29, Issue:11 Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Guanidines; Guidelines as Topic; Humans; Infant; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Randomized Controlled Trials as Topic; Sialic Acids; Treatment Outcome; Zanamivir	2000
Flu-fighting options: decisions, decisions.... Health news (Waltham, Mass.), 2000, Volume: 6, Issue:12 Topics: Acetamides; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza, Human; Oseltamivir; Pneumonia; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2000
Zanamivir. No noticeable progress against influenza. Canadian family physician Medecin de famille canadien, 2000, Volume: 46 Topics: Amantadine; Antiviral Agents; Cost-Benefit Analysis; Drug Costs; Guanidines; Humans; Influenza, Human; Pyrans; Sialic Acids; Zanamivir	2000
Unprepared for an influenza pandemic. Lancet (London, England), 2001, Aug-25, Volume: 358, Issue:9282 Topics: Acetamides; Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Microbial; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Sialic Acids; Zanamivir	2001
ACIP releases guidelines on the prevention and control of influenza. Advisory Committee on Immunization Practices. American family physician, 2001, Oct-01, Volume: 64, Issue:7 Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Patient Selection; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2001
Influenza vaccine, anti-influenza drugs, and rapid diagnosis in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2000, Volume: 6, Issue:2 Topics: Amantadine; Antiviral Agents; Child; Child, Preschool; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Male; Neuraminidase; Pyrans; Reagent Kits, Diagnostic; Sialic Acids; Vaccination; Zanamivir	2000
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2002, Apr-12, Volume: 51, Issue:RR-3 Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Cost-Benefit Analysis; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Rimantadine; Risk Factors; Sialic Acids; United States; Vaccination; Zanamivir	2002
Cost-effectiveness of newer treatment strategies for influenza. The American journal of medicine, 2002, Volume: 113, Issue:4 Topics: Acetamides; Adult; Age Distribution; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Cost-Benefit Analysis; Decision Trees; Diagnostic Tests, Routine; Drug Costs; Female; Guanidines; Humans; Influenza, Human; Male; Middle Aged; Monte Carlo Method; Neuraminidase; Oseltamivir; Pennsylvania; Pyrans; Quality-Adjusted Life Years; Sialic Acids; Zanamivir	2002
Compared protective effect of nasal immunoprophylaxis using a new human monoclonal IgM antibody, human polyclonal antibodies, F(ab')2, amantadine, and zanamivir for prophylaxis of influenza A virus pneumonia in mice. Military medicine, 2003, Volume: 168, Issue:3 Topics: Amantadine; Animals; Antibodies, Monoclonal; Antiviral Agents; Female; Guanidines; Humans; Immunization, Passive; Immunoglobulin Fab Fragments; Immunoglobulin M; Immunoglobulins, Intravenous; Influenza A virus; Influenza, Human; Mice; Mice, Inbred BALB C; Pneumonia, Viral; Pyrans; Sialic Acids; Zanamivir	2003
Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Annals of internal medicine, 2003, Sep-02, Volume: 139, Issue:5 Pt 1 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir	2003
Summaries for patients. Cost-effective management of flu in adults older than 65 years of age. Annals of internal medicine, 2003, Sep-02, Volume: 139, Issue:5 Pt 1 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir	2003
Assessment of development of resistance to antivirals in the ferret model of influenza virus infection. The Journal of infectious diseases, 2003, Nov-01, Volume: 188, Issue:9 Topics: Amantadine; Animals; Antiviral Agents; Disease Models, Animal; Drug Resistance, Viral; Ferrets; Guanidines; Hemagglutination Inhibition Tests; Influenza A virus; Male; Orthomyxoviridae Infections; Point Mutation; Pyrans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sequence Analysis, DNA; Sialic Acids; Zanamivir	2003
[Treatment of influenza in children]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2003, Volume: 41, Issue:2 Topics: Adamantane; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2003
Influenza infection of the embryonated hen's egg/an alternative model for in vivo evaluation of antiviral compounds. Arzneimittel-Forschung, 2004, Volume: 54, Issue:2 Topics: Amantadine; Animals; Antiviral Agents; Chick Embryo; Drug Evaluation, Preclinical; Guanidines; Influenza A virus; Orthomyxoviridae Infections; Pyrans; Rimantadine; Sialic Acids; Survival Analysis; Zanamivir	2004
Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy. The Medical journal of Australia, 2004, Jun-21, Volume: 180, Issue:12 Topics: Acetamides; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Disease Outbreaks; Female; Guanidines; Homes for the Aged; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Influenza A virus; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Sialic Acids; Vaccination; Victoria; Zanamivir	2004
Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 31, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Drug Resistance, Viral; Germany; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Primary Health Care; Pyrans; Sialic Acids; Zanamivir	2004
Avian influenza should be ruffling our feathers. The Lancet. Infectious diseases, 2004, Volume: 4, Issue:10 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Asia, Eastern; Asia, Southeastern; Birds; Disease Outbreaks; Guanidines; Humans; Influenza in Birds; Influenza Vaccines; Influenza, Human; International Cooperation; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; World Health Organization; Zanamivir	2004
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors. Medical microbiology and immunology, 2006, Volume: 195, Issue:2 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Chick Embryo; Chickens; Enzyme Inhibitors; Guanidines; Influenza A virus; Influenza in Birds; Microbial Sensitivity Tests; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2006
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral research, 2007, Volume: 73, Issue:3 Topics: Acids, Carbocyclic; Amantadine; Animals; Antiviral Agents; Base Sequence; Birds; Cyclopentanes; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir	2007
Antiviral management of seasonal and pandemic influenza. The Journal of infectious diseases, 2006, Nov-01, Volume: 194 Suppl 2 Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza, Human; Mice; Neuraminidase; Oseltamivir; Rimantadine; Seasons; Zanamivir	2006
[Significance of virological diagnostics for the effective treatment of hospitalized patients infected with influenza virus]. Pneumonologia i alergologia polska, 2006, Volume: 74, Issue:2 Topics: Adult; Amantadine; Antiviral Agents; Diagnosis, Differential; Fluorescent Antibody Technique; Hospitalization; Humans; Influenza A virus; Influenza, Human; Middle Aged; Oseltamivir; Respiratory Tract Diseases; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; Treatment Outcome; Zanamivir	2006
Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best. Prescrire international, 2007, Volume: 16, Issue:87 Topics: Amantadine; Antiviral Agents; Child; Drug Approval; Drug Resistance; Europe; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Vaccination; Zanamivir	2007
Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999. Antiviral research, 2007, Volume: 75, Issue:3 Topics: Amantadine; Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Drug Resistance, Viral; Enzyme Inhibitors; Germany; Hemagglutination, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Influenza A Virus, H3N2 Subtype; Neuraminidase; Oseltamivir; Swine; Zanamivir	2007
Influenza. Canadian family physician Medecin de famille canadien, 2008, Volume: 54, Issue:3 Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Mass Vaccination; Oseltamivir; Rimantadine; Zanamivir	2008
Antivirals and influenza: frequency of resistance. The Pediatric infectious disease journal, 2008, Volume: 27, Issue:10 Suppl Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir	2008
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; Genetic Markers; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, RNA; Zanamivir	2009
Rare influenza A (H3N2) variants with reduced sensitivity to antiviral drugs. Emerging infectious diseases, 2010, Volume: 16, Issue:3 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Myanmar; Neuraminidase; Phylogeny; Sequence Analysis, DNA; Viral Matrix Proteins; Viral Proteins; Zanamivir	2010
Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan. Emerging infectious diseases, 2010, Volume: 16, Issue:6 Topics: Amantadine; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Hemagglutination Inhibition Tests; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Neuraminidase; Oseltamivir; Phylogeny; Seasons; Sequence Analysis, Protein; Time Factors; Viral Matrix Proteins; Zanamivir	2010
Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season. Journal of medical virology, 2010, Volume: 82, Issue:7 Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Child, Preschool; Dogs; Drug Resistance, Viral; Environmental Monitoring; Epidemiological Monitoring; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lebanon; Male; Microbial Sensitivity Tests; Oseltamivir; Phylogeny; Seasons; Zanamivir	2010
[Naturally occurring oseltamivir resistance in influenza A]. Ugeskrift for laeger, 2010, Aug-09, Volume: 172, Issue:32 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Zanamivir	2010
Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008-2009). Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:4 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Amantadine; Amino Acid Sequence; Analysis of Variance; Antiviral Agents; Body Temperature; Child; Child, Preschool; Disease Outbreaks; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Japan; Middle Aged; Molecular Sequence Data; Mutation; Oseltamivir; Seasons; Sequence Alignment; Treatment Outcome; Viral Matrix Proteins; Zanamivir	2011
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. The Journal of infectious diseases, 2011, Dec-15, Volume: 204, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Guideline Adherence; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Odds Ratio; Oseltamivir; Pandemics; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Rimantadine; United States; Young Adult; Zanamivir	2011
Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008. Revista panamericana de salud publica = Pan American journal of public health, 2011, Volume: 30, Issue:6 Topics: Amantadine; Animals; Antiviral Agents; Argentina; Cell Line; Dogs; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Morbidity; Mutation, Missense; Neuraminidase; Oseltamivir; Point Mutation; Population Surveillance; Seasons; Virus Cultivation; Zanamivir	2011
Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreak. Environmental science & technology, 2012, Dec-04, Volume: 46, Issue:23 Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Environmental Monitoring; Humans; Influenza, Human; Japan; Oseltamivir; Rivers; Sewage; Water Pollutants, Chemical; Zanamivir	2012
[Establishment of drug screening assay and pharmacodynamic evaluation method targeting influenza RNA polymerase]. Yao xue xue bao = Acta pharmaceutica Sinica, 2012, Volume: 47, Issue:9 Topics: Alphainfluenzavirus; Amantadine; Antiviral Agents; Drug Evaluation, Preclinical; Genes, Reporter; HEK293 Cells; Humans; Luciferases; Oseltamivir; Plasmids; Reproducibility of Results; Ribavirin; RNA-Dependent RNA Polymerase; Sensitivity and Specificity; Transfection; Zanamivir	2012
Characterization of human Influenza Viruses in Lebanon during 2010-2011 and 2011-2012 post-pandemic seasons. Intervirology, 2014, Volume: 57, Issue:6 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lebanon; Microbial Sensitivity Tests; Mutation; Neuraminidase; Oseltamivir; Pandemics; Phylogeny; Pyrans; Sialic Acids; Zanamivir	2014